Introduction {#Sec1}
============

Acute ischemic stroke induces damage to the blood-brain barrier (BBB) \[[@CR1]\]. Alterations in the BBB integrity related to stroke severity, duration of ischemia and reperfusion have been associated with development of hemorrhagic transformation (HT) \[[@CR1]--[@CR3]\]. BBB permeability (BBBP) can be calculated from CT perfusion (CTP) data by obtaining an extended CTP acquisition and measuring progressive leakage of iodinated contrast out of the cerebral vessels \[[@CR4]\]. As currently many stroke clinics routinely obtain CTP on admission in stroke patients, BBBP measurements with CTP could be a practical addition in prognostic and diagnostic stroke imaging \[[@CR5]\]. To better understand the concept of permeability, thorough evaluation of BBBP measurements with CTP in stroke patients is required.

On arrival to the emergency department, the severity of stroke and ischemic damage differs considerably between patients. Since ischemia is thought to alter BBB integrity, BBBP is likely to be related to stroke severity at the time of CT scanning at admission. Furthermore, several factors intrinsic to the patient have been associated with increased BBBP. These factors include age, elevated diastolic pressure, increased glucose levels and atrial fibrillation \[[@CR3], [@CR6]--[@CR8]\]. If BBBP measurements are an indicator of ischemic damage to the BBB there should be a relationship between these factors and CTP BBBP measurements at time of admission.

The purpose of this study was to evaluate the relationship between stroke severity, patient characteristics, and CTP BBB permeability values in a consecutive prospectively collected series of acute ischemic middle cerebral artery (MCA) stroke patients.

Materials and methods {#Sec2}
=====================

Study design {#Sec3}
------------

In this study we used data from the Dutch Acute Stroke Study (DUST). This is a large multicenter cohort study which aims to assess the additional value of CTP and CT angiography (CTA) in predicting outcome of acute ischemic stroke patients. Prospective inclusion was done between May 2009 and August 2013, and patients were enrolled in 14 DUST hospitals \[[@CR9]\].

Inclusion criteria for this study were: age ≥ 18 years, suspected ischemic stroke of less then 9 h duration and National Institute of Health Stroke Scale (NIHSS) score of ≥ 2 (or 1 if an indication for thrombolysis was present). Exclusion criteria were known renal failure or contraindications to iodinated contrast material. This study was approved by the central ethics committee in the UMC Utrecht as well as the local institutional ethical review boards of the participating centers. All patients or family gave signed informed consent, unless a patient died before consent could be obtained. The need for consent in that case was waived by the medical ethics committee \[[@CR9]\]. From this study database consecutive patients were selected from seven centers (Catharina Hospital Eindhoven, Leiden University Medical Center, Rijnstate Hospital Arnhem, St. Elizabeth Hospital Tilburg, St. Franciscus Hospital Rotterdam, University Medical Center Utrecht, VU Medical Center Amsterdam). We selected these centers from all DUST centers because of their respective start date of inclusion and availability of the data at the time of patient selection for this study.

Additional inclusion criteria for this study were: admission between May 2009 and July 2011 with a CTP deficit in the region of the middle cerebral artery and an extended CTP acquisition. Exclusion criteria were technical failure of the extended CTP (incomplete scan series, excessive movement or artifacts).

General baseline patient characteristics were collected on admission: age, sex, prior history of cardiovascular risk factors obtained by anamnesis (stroke, hypertension, diabetes, hyperlipidemia, angina, myocardial infarction), NIHSS, time from stroke onset to admission CT scan and blood glucose (mmol/l). Determinants were selected on the basis of prevalence in stroke population and potential influence on the integrity of the BBB.

Imaging protocol {#Sec4}
----------------

Non contrast brain CT (NCCT), CTP with extended acquisition, and CTA of the cervical and cerebral vessel were performed on admission before possible thrombolytic treatment was initiated. Multi-detector CT scanners used were Philips iCT 256-detector, Philips 64-detector, Philips 40-detector, Toshiba 320-detector and Toshiba 64-detector. CT protocols were adjusted to scanner type and contrast agent used.

The CTP involved successive gantry rotations in cine mode during intravenous administration of iodinated contrast material (40 ml non-ionic contrast followed by 40 ml of saline with a flow of 6 ml/sec). Temporal sampling was obtained every 2 s for 50 s followed by six samples 30 s apart at 60, 90, 120, 150, 180 and 210 s. Only the Philips scanners required a separate scan to change the cycle time and the two separate scans were fused prior to permeability measurements. The Toshiba 320-detector scanner had full brain coverage. The other CT scanners had a coverage of 40--65 mm (8--13 5 mm slices) from at least the level of the basal ganglia to the lateral ventricles to be able to compare between patients.

Following CTP, a CTA was performed from aortic arch to the vertex with 50--70 ml non-ionic contrast. The CTA data was not used for this study. All data and imaging processing was done centrally in Utrecht University Medical Center.

Image post processing {#Sec5}
---------------------

Cerebral blood volume (CBV), cerebral blood flow (CBF), mean transit time (MTT) and time to peak (TTP) were automatically calculated from CTP data utilizing commercially available CTP software (Extended Brilliance workstation 4.5, Philips Healthcare). The internal carotid artery (if available in the scan range) or anterior cerebral artery was chosen as arterial input function \[[@CR10]\]. The superior saggital sinus was used as venous output function. A MTT threshold of 145 % compared to non-affected side was used to define the ischemic area. Within this area a CBV value of less then 2.0 ml/100 g was used to define the infarct core and a CBV of 2.0 ml/100 g or more to define the penumbra \[[@CR5]\].

BBBP was calculated with a commercially available software based on the Patlak model (Intellispace Portal system, Philips Healthcare) \[[@CR11]\]. The Patlak model involves the fitting of a regression line to observations of time-density curves for each pixel and for intravascular reference function. The slope of these lines represents a local blood-to-brain transfer constant and is an indicator of BBBP values (perfusion derived permeability surface area product (PS) in ml/min/100 g). To minimize the influence of larger size vessels, pixels with a CBV \> 9 ml/100 g were removed. Circular ROIs of identical size (100 mm^2^) were drawn in the center of the CTP threshold defined penumbra and infarct core and mirror-imaged regions of interest (ROIs) were automatically drawn in the contra-lateral hemisphere (Fig. [1](#Fig1){ref-type="fig"}). To correct for the potential influence of CBF, extraction ratio ((BBBP/CBF) × 100 %) values were obtained in all four ROIs \[[@CR12], [@CR13]\]. All measurements were done blinded to other study data.Fig. 1Drawing of ROIs in infarct core and penumbra

Image analysis {#Sec6}
--------------

On the admission NCCT, the presence of early CT signs (ECTS), defined as hypodensity with or without swelling, and presence of a dense vessel sign (DVS) were evaluated by one of three observers (I.C.vdS, B.K.V and J.W.D), all with at least 5 years of experience in stroke imaging. The side of symptoms was provided but observers were blinded to other clinical and imaging data. Consensus was reached for all discrepant findings.

Statistical analysis {#Sec7}
--------------------

Outcomes were BBBP in the penumbra- and infarct ROI and the contra-lateral hemisphere as well as BBBP ratios (ipsi-lateral/contra-lateral), and extraction ratio in both ROI's \[[@CR14]\]. Variables referring to stroke severity were NIHSS (rearranged into quintiles), DVS, ECTS, and penumbra- and infarct size. Patient variables were age, sex, cardiovascular risk factors and glucose. Cardiovascular risk factors were dichotomized and considered positive if medical history included one of the following: hyperlipidemia, hypertension, diabetes, angina pectoris, myocardial infarction or atrial fibrillation. Prior to analysis outcome data were truncated to 5--95 % to adjust for outliers. Statistical computations were carried out using SPSS 19.0 (IBM corporation, NY, USA). The relation between the determinants and permeability values was quantified with regression analysis. In the multivariate analysis all variables were initially included and then sequentially removed with a probability-to-enter of 0.05 until only significant predictors remained (p 0.10).

Results {#Sec8}
=======

The inclusion criteria were met in 196 patients and 47 were subsequently excluded because of failed acquisition (22), motion artifacts (19) and beam hardening artifacts (6). Of the remaining 149 patients the stroke severity parameters and patient characteristics are summarized in Table [1](#Tab1){ref-type="table"}.Table 1Patient, stroke and imaging characteristicsNumber of patients149Age in years, median (IQ range)69 (59--80)Sex, men %54*Patient characteristics:*Cardiovascular risk factors, one or more of the following %71Angina %10Myocardial infarction %13Atrial fibrillation %13Diabetes %16Hyperlipidemia %30Hypertension %57Glucose in mmol/l, median (IQ range)7.1 (5.8--7.6)*Stroke severity:*NIHSS, mean (median, range)10 (8, 1--32)Time from symptom onset to scan in hours, mean (median, range)3.0 (2.2, 0.47--9)0--3 h %603--4.5 h %244.5--6 h %96--9 h %7*Imaging parameters:*Dense vessel sign (DVS) %34Early CT signs (ECTS) %38Penumbra size in cm^2^, median (IQ range)21 (6--40)Infarct size in cm^2^, median (IQ range)5 (1--17)

Outcome values are shown in Table [2](#Tab2){ref-type="table"}. The median permeability value in the ipsi-lateral penumbra was 1.89 and in the infarct core 1.74; contra-lateral values were 1.71 and 1.59 respectively. The median extraction ratio in the infarct core was 17 and 10 % for the penumbra, and respectively 4 and 3 % on the contra-lateral side, with wide distribution. The median ratio of BBBP values between the ipsi-lateral and the mirrored contra-lateral area was 0.97 for the infarct core and 1.14 in the penumbra.Table 2Median BBB Permeability measurementsIpsi-lateral (IQ range)Contra-lateral (IQ range)*P*-valueBBB Permeability (in ml/100gr/min)Penumbra1.89 (1.23--2.79)1.71 (1.15--2.73)0.3Infarct core1.74 (0.90--2.99)1.59 (1.03--2.59)0.6Extraction ratio (BBB Permeability/ CBF \*100 %)Penumbra10.1 (5.65--16.76)3.2 (2.16--6.18)^a^Infarct core16.7 (9.38--33.26)4.1 (2.21--7.57)^a^Ratio BBB Permeability ipsi-lateral/ contra-lateralPenumbra1.1 (0.79--1.61)N/AInfarct core1.0 (0.67--1.53)N/A^a^Mann-Whitney U test not performed due to large difference in range between samples

Univariate analysis (Table [3](#Tab3){ref-type="table"}) showed significantly higher BBBP values in the infarct core (B = 0.276) in the presence of ECTS but not in the penumbra or contra-lateral ROIs. ECTS (B = 18.7) and infarct size (B = 0.463) were also related to higher extraction ratio in the infarct core. Additionally, lower permeability values in penumbra (B = − 0.495) and infarct core (B = − 0.786) were found in female patients. All other parameters, including dense vessel sign, did not show significantly higher or lower BBBP values.Table 3Univariate analysis of the relation between stroke severity, patient characteristics and BBB Permeability values (in penumbra and infarct core), and extraction ratio and BBB Permeability ratio (in infarct core)Outcome:BBB Permeability penumbraBBB Permeability infarct coreExtraction ratio infarct coreBBB Permeability ratio infarct corePredictor:B95 % CIB95 % CIB95 % CIB95 % CIAge (in years)− 0.008− 0.026--0.010− 0.020− 0.042--0.003− 0.197− 0.633--0.238− 0.006− 0.018--0.006Female sex− 0.495\*− 0.958 -- − 0.032− 0.786\*− 1.386 -- − 0.186− 11.251− 22.540--0.038− 0.097− 0.428--0.235NIHSS^a^− 0.043− 0.217--0.131− 0.007− 0.238--0.2232.200− 2.032--6.432− 0.081− 0.204--0.042Time to scan^b^0.008− 0.097--0.1120.049− 0.090--0.188− 0.260− 2.794--2.2730.013− 0.062--0.087Cardiovascular risk factors (yes/no)^c^0.222− 0.280--0.725− 0.065− 0.726--0.5962.731− 9.550--15.0120.167− 0.189--0.523Glucose (mmol/l)0.064− 0.083--0.2120.012− 0.180--0.2042.247− 1.122--5.616− 0.019− 0.124--0.085Dense vessel sign (yes/no)0.134− 0.360--0.6290.374− 0.256--1.0047.213− 4.742--19.167− 0.188− 0.526--0.151Early CT signs (yes/no)0.232− 0.247--0.7120.819\*0.214--1.42418.709\*7.397--30.0200.276− 0.055--0.607Penumbra size (cm^2^)0.003− 0.009--0.0150.010− 0.005--0.0260.228− 0.063--0.520− 0.005− 0.013--0.004Infarct size (cm^2^)− 0.003− 0.020--0.0130.007− 0.014--0.0290.463\*0.062--0.864− 0.003− 0.014--0.009^a^In 5 categories: 1--3, 4--6, 7--12, 13--17 and 18 or higher^b^In 4 categories: 0--3, 3--4, 5 4.5--6 and 6--9 h^c^Any from: hyperlipidemia, hypertension, diabetes, angina pectoris, myocardial infarction or atrial fibrillation\**P* \< 0.05

In multivariate analysis (Table [4](#Tab4){ref-type="table"}) ECTS were related to higher BBBP values in the infarct core (B = 0.710), higher ipsi- to contra-lateral BBBP ratios (B = 0.326) and higher extraction ratios in the infarct core (B = 16.938). Females showed lower BBBP values in penumbra and infarct core (B = − 0.446 and − 0.776 respectively) and lower extraction ratios in the infarct core (B = − 10.463). If a DVS is present the ipsi- to contra-lateral BBBP ratios in the infarct core were lower (B = − 0.304).Table 4Multivariate analysis of the relation between stroke severity, patient characteristics and BBB Permeability values (in penumbra and infarct core) and extraction ratio and BBB Permeability ratio (in infarct core)BBB Permeability penumbraBBB Permeability infarct coreExtraction ratio infarct coreBBB Permeability ratio infarct corePredictorB95 % CIPredictorB95 % CIPredictorB95 % CIPredictorB95 % CIFemale sex− 0.446− 0.909--0.016Female sex− 0.776− 1.358 -- − 0.194Female sex− 10.463− 20.665 -- − 0.271Early CT signs0.7100.120--1.300Early CT signs16.9386.449--27.427Early CT signs0.326− 0.026--0.679Dense vessel sign (DVS)− 0.304− 0.660--0.053All *P* \< 0.10

Discussion {#Sec9}
==========

The most important finding in this study is that only ECTS are related to higher permeability values in the infarct core on admission, when calculated using the Patlak model. No significant differences were found between median BBBP values in the penumbra, infarct core and the unaffected contra-lateral hemisphere.

Median infarct BBBP values in our study fall in the range of previously published values (0.34--3.5 ml/100gr/min) \[[@CR15]--[@CR18]\]. Median penumbra BBBP values have only been published in one study with a value of 2.48 ml/100gr/min, which was higher than the value found in this study \[[@CR19]\]. Unfortunately, we could not find any significant difference between values calculated in the different brain tissue types. Also, the ratio of permeability in the infarct core and the penumbra compared to the contra-lateral side was close to one, further that measured permeability values were similar in both hemispheres. This raises serious concerns about the applied technique. The finding that BBBP calculated with the Patlak model is not zero in the unaffected hemisphere suggests that a large level of noise influences the measurement of permeability in the used CTP acquisitions. The absence of differences between the different tissue types implies that the signal from the leaked contrast is not large enough to overcome the level of noise. Advanced noise filtering may be a solution to these problems \[[@CR20]\]. The lack of signal will most likely be largest in an area of least flow, since hardly any contrast enters the tissue and can therefore not leak out. Our intention to overcome this issue by calculating the extraction ratio did result in more obvious differences between the tissue types, however with a very wide distribution.

In our multivariate analysis of factors describing stroke severity on BBBP only ECTS showed a positive relationship with higher BBBP values. Since ECTS are a sign of severe and often irreversible ischemia, our findings suggest that only severe ischemia induces measurable BBB breakdown within the first hours after acute ischemic stroke \[[@CR21], [@CR22]\]. The size of the ischemic deficit does not seem to influence BBBP values, as there is no significant relationship with infarct core or penumbra size. It still needs to be evaluated whether BBBP is a better predictor of HT in comparison to ECTS.

The lower ipsi-lateral to contra-lateral ratios of BBBP found in the infarct core when a dense vessel sign is present is difficult to explain as we expected higher- instead of lower values. A DVS has a high specificity and positive predictive value for diagnosing acute occlusion of the M1 segment of the MCA \[[@CR23], [@CR24]\]. In some articles a DVS in the MCA is associated with more severe neurologic deficit at presentation, more extensive area of brain infarction, and worse neurologic outcome after thrombolysis \[[@CR23]--[@CR25]\]. In contrast, other studies found no relation between DVS and poor outcome \[[@CR26]--[@CR29]\]. A possible explanation for the lower values in this study is that hyperdense MCA sign (M1 segment) and MCA dot sign (M2 or higher) were grouped together although the prognosis of a M2 segment MCA occlusion was found to be better by Barber et al. 2001 \[[@CR30]\]. Secondly, DVS is related to local vessel occlusion but this does not necessarily lead to tissue hypo-perfusion if distal collaterals provide sufficient perfusion.

Of the factors describing patient characteristics only female gender was associated with lower BBBP values. There are clear gender differences in acute ischemic stroke and estrogens and pro-inflammatory cytokine production during cerebral ischemia are thought to be related to these differences \[[@CR31], [@CR32]\]. The relationship between female sex and reduced disruption of the BBB has been found in several animal studies but so far could not be confirmed in human studies \[[@CR19], [@CR33]--[@CR36]\]. Our study with human subjects does confirm that some relation between female sex and BBB integrity in acute ischemic stroke exists, but further studies are still needed to clarify this issue. In contrast to Bang et al. 2009, age and NIHSS were not related to significant differences in permeability values \[[@CR6]\].

Besides the low signal-to-noise ratio of the BBBP measurements with the Patlak model from CTP data we acknowledge several other limitations to our study. First, we had to exclude nearly 25 % of patients due to technical failure of the CTP. Compared to the numbers found in other studies our percentage is rather high. The technical failure was largely related to the extended acquisition necessary to calculate BBBP with the Patlak model \[[@CR4], [@CR17]\]. At present, not all CT vendors can change the cycle time from the initial two-second cycle time to the 30 s extended cycle time. This requires two separate perfusion scans which can cause difficulty in merging the two datasets for analysis. In addition, extending the acquisition time from 50 to 210 s also increases the risk of motion artefacts, which are especially difficult to correct in the z-direction. Second, we only used the Patlak model in this study which assumes unidirectional transfer without backflow and requires steady state contrast levels. This assumption is possibly not sufficiently accurate and technical improvement with other models (e.g. distributed parameter model) needs to be tested. The first results of such a model have been published recently \[[@CR37]\]. Measurable BBBP values above the noise level are prerequisite to be able to predict possible hemorrhagic transformation. Third, No gold standard for the definition of infarct core and penumbra with CTP has been established so far. It is possible that when using other thresholds described in literature, the ROI's would have been different, resulting in other permeability values that might have correlated differently with BBBP. However, the definition of infarct core and penumbra we used has frequently been applied in literature and is the default setting in the post-processing software we used. This makes our results more reproducible for general stroke work-up when this software is used.

In conclusion, BBB permeability assessment with the Patlak model from CTP acquisition in stroke patients is technically challenging and limited by the current signal-to-noise ratio. In this study we found higher BBBP measurements when early ischemic changes on admission NCCT are present. This suggests that severe ischemic damage results in measurable BBBP alterations within the first hours after symptom onset.
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